Physician profile
Kara Monday
NPI 1174815765
$11,949.02
in general payments reported to CMS, 2019-2025
37 companies · $2,090 in 2025
The $2,090 reported for 2025 was more than what 77% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $205 · 2021: $206 · 2022: $2,970 · 2023: $1,180 · 2024: $4,600 · 2025: $2,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,053 · Education: $2,500 · Travel and Lodging: $2,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,052.63 |
| Education | $2,500.00 |
| Travel and Lodging | $2,318.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,379.62 | 2024-2025 | |
| Transmedics, INC. | $2,171.20 | 2022 | |
| Abbott Laboratories | $1,984.31 | 2019-2024 | 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $1,235.77 | 2024 | Mc3 Nautilus(Tm) Ecmo Oxygenator, Biomedicus |
| Livanova USA, INC. | $265.47 | 2022-2023 | Lifesparc |
| Abiomed | $245.08 | 2023 | Impella |
| La Jolla Pharmaceutical Company | $204.91 | 2022-2024 | Giapreza |
| Boston Scientific Corporation | $196.31 | 2024-2025 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $152.47 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Medtronic Vascular, INC. | $133.04 | 2019 | |
| Fresenius USA Marketing, INC. | $79.54 | 2021 | |
| Kci USA, INC. | $79.27 | 2020-2023 | Prevena, Abthera Advance, V.A.C. Veraflo |
| Aroa Biosurgery Incorporated | $74.23 | 2022-2025 | |
| Paragonix Technologies, INC. | $64.33 | 2024 | Pancreaspak, Liverguard, Sherpapak |
| Mallinckrodt Enterprises LLC | $58.57 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $55.24 | 2019 | |
| Kls-Martin L.P. | $50.08 | 2025 | |
| Csl Behring | $45.75 | 2020 | |
| Allergan, INC. | $44.80 | 2019 | |
| Teleflex LLC | $40.36 | 2021-2024 | Arrow |
| Nestle Healthcare Nutrition INC. | $37.78 | 2021 | |
| Shionogi INC | $32.49 | 2023-2024 | Fetroja |
| Acell, INC. | $31.94 | 2019 | |
| Tei Biosciences INC | $28.42 | 2019 | |
| Potrero Medical, INC. | $25.42 | 2021 | |
| Kerecis Limited | $25.35 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Atricure, INC. | $24.47 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Melinta Therapeutics, LLC | $23.93 | 2023 | Vabomere, Rezzayo |
| Integra Lifesciences Corporation | $22.53 | 2021 | |
| Saranas, INC. | $21.76 | 2023 | |
| Z-Medica, LLC | $21.42 | 2020 | |
| Smith+Nephew, INC. | $21.33 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.80 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $17.65 | 2019 | |
| Cook Medical LLC | $13.55 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.41 | 2019 | |
| Bolder Surgical LLC | $7.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Monday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.